Hypothalamic actions of neuromedin U

Endocrinology

Volumn 143, Issue 11, 2002, Pages 4227-4234

  Wren, A M ^a   Small, C J ^a   Abbott, C R ^a   Jethwa, P H ^a   Kennedy, A R ^a   Murphy, K G ^a   Stanley, S A ^a   Zollner, A N ^a   Ghatei, M A ^a   Bloom, S R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; LEPTIN; NEUROMEDIN U;

ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DOSE RESPONSE; FOOD INTAKE; GROOMING; HORMONE ACTION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 0036827997     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220308     Document Type: Article

References (46)

1. Minamino N, Kangawa K, Matsuo H 1985 Neuromedin U-8 and U-25: Novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem Biophys Res Commun 130:1078-1085
2. Sumi S, Inoue K, Kogire M, Doi R, Takaori K, Suzuki T, Yajima H, Tobe T 1987 Effect of synthetic neuromedin U-8 and U-25, novel peptides identified in porcine spinal cord, on splanchnic circulation in dogs. Life Sci 41:1585-1590
3. Gardiner SM, Compton AM, Bennett T, Domin J, Bloom SR 1990 Regional hemodynamic effects of neuromedin U in conscious rats. Am J Physiol 258: R32-R38
4. O'Harte F, Bockman CS, Abel PW, Conlon JM 1991 Isolation, structural characterization and pharmacological activity of dog neuromedin U. Peptides 12:11-15
5. Kage R, O'Harte F, Thim L, Conlon JM 1991 Rabbit neuromedin U-25: Lack of conservation of a posttranslational processing site. Regul Pept 33:191-198
6. Domin J, Yiangou YG, Spokes RA, Aitken A, Parmar KB, Chrysanthou BJ, Bloom SR 1989 The distribution, purification, and pharmacological action of an amphibian neuromedin U. J Biol Chem 264:20881-20885
7. Austin C, Lo G, Nandha KA, Meleagros L, Bloom SR 1995 Cloning and characterization of the cDNA encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal tract. J Mol Endocrinol 14:157-169
8. Conlon JM, Domin J, Thim L, DiMarzo V, Morris HR, Bloom SR 1988 Primary structure of neuromedin U from the rat. J Neurochem 51:988-991
9. Minamino N, Kangawa K, Honzawa M, Matsuo H 1988 Isolation and structural determination of rat neuromedin U. Biochem Biophys Res Commun 156:355-360
10. Domin J, Ghatei MA, Chohan P, Bloom SR 1986 Characterization of neuromedin U like immunoreactivity in rat, porcine, guinea-pig and human tissue extracts using a specific radioimmunoassay. Biochem Biophys Res Commun 140:1127-1134
11. Domin J, Al Madani AM, Desperbasques M, Bishop AE, Polak JM, Bloom SR 1990 Neuromedin U-like immunoreactivity in the thyroid gland of the rat. Cell Tissue Res 260:131-135
12. Honzawa M, Sudoh T, Minamino N, Tohyama M, Matsuo H 1987 Topographic localization of neuromedin U-like structures in the rat brain: An immunohistochemical study. Neuroscience 23:1103-1122
13. Ballesta J, Carlei F, Bishop AE, Steel JH, Gibson SJ, Fahey M, Hennessey R, Domin J, Bloom SR, Polak JM 1988 Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat. Neuroscience 25:797-816
14. Domin J, Ghatei MA, Chohan P, Bloom SR 1987 Neuromedin U: A study of its distribution in the rat. Peptides 8:779-784
15. Howard AD, Wang R, Pong SS, Mellin TN, Strack A, Guan XM, Zeng Z, Williams DL, Jr., Feighner SD, Nunes CN, Murphy B, Stair JN, Yu H, Jiang Q, Clements MK, Tan CP, McKee KK, Hreniuk DL, McDonald TP, Lynch KR, Evans JF, Austin CP, Caskey CT, van der Ploeg LH, Liu Q 2000 Identification of receptors for neuromedin U and its role in feeding. Nature 406: 70-74
16. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS 1999 Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20:68-100
17. Raddatz R, Wilson AE, Artymyshyn R, Bonini JA, Borowsky B, Boteju LW, Zhou S, Kouranova EV, Nagorny R, Guevarra MS, Dai M, Lerman GS, Vaysse PJ, Branchek TA, Gerald C, Forray C, Adham N 2000 Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J Biol Chem 275:32452-32459
18. Szekeres PG, Muir AI, Spinage LD, Miller JE, Butler SI, Smith A, Rennie GI, Murdock PR, Fitzgerald LR, Wu H, McMillan LJ, Guerrera S, Vawter L, Elshourbagy NA, Mooney JL, Bergsma DJ, Wilson S, Chambers JK 2000 Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J Biol Chem 275:20247-20250
19. Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Habata Y, Hinuma S, Onda H, Nishimura O, Fujino M 2000 Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J Biol Chem 275:21068-21074
20. Kojima M, Haruno R, Nakazato M, Date Y, Murakami N, Hanada R, Matsuo H, Kangawa K 2000 Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem Biophys Res Commun 276:435-438
21. Guan XM, Yu H, Jiang Q, van der Ploeg LH, Liu J 2001 Distribution of neuromedin U receptor subtype 2 mRNA in the rat brain. Gene Expression Patterns 1:1-4
22. Stanley BG, Chin AS, Leibowitz SF 1985 Feeding and drinking elicited by central injection of neuropeptide Y: Evidence for a hypothalamic site(s) of action. Brain Res Bull 14:521-524
23. Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF 1990 Stimulation of feeding by galanin: Anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 11:995-1001
24. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ, Edwards CM, Heath MM, Stanley SA, Seal LJ, Bhatti JR, Smith DM, Ghatei MA, Bloom SR 2000 Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes 49: 177-182
25. Gillies G, Lowry P 1979 Corticotrophin releasing factor may be modulated vasopressin. Nature 278:463-464
26. Pacak K, Palkovits M 2001 Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders. Endocr Rev 22:502-548
27. Cimini V, Van Noorden S, Timson CM, Polak JM 1993 Modulation of galanin and neuromedin U-like immunoreactivity in rat corticotropes after alteration of endocrine status. Cell Tissue Res 272:137-146
28. Steel JH, Van Noorden S, Ballesta J, Gibson SJ, Ghatei MA, Burrin J, Leonhardt U, Domin J, Bloom SR, Polak JM 1988 Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors. Endocrinology 122:270-282
29. Malendowicz LK, Andreis PG, Markowska A, Nowak M, Warchol JB, Neri G, Nussdorfer GG 1994 Effects of neuromedin U-8 on the secretory activity of the rat adrenal cortex: Evidence for an indirect action requiring the presence of the zona medullaris. Res Exp Med 194:69-79
30. Malendowicz LK, Nussdorfer GG, Markowska A, Tortorella C, Nowak M, Warchol JB 1994 Effects of neuromedin U (NMU)-8 on the rat hypothalamo-pituitary-adrenal axis. Evidence of a direct effect of NMU-8 on the adrenal gland. Neuropeptides 26:47-53
31. Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM, Edwards CM, Abusnana S, Sunter D, Ghatei MA, Bloom SR 2000 The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 105:1005-1011
32. Paxinos G, Watson C 1998 The Rat Brain. New York: Academic Press
33. Stanley SA, Small CJ, Kim MS, Heath MM, Seal LJ, Russell SH, Ghatei MA, Bloom SR 1999 Agouti related peptide (Agrp) stimulates the hypothalamo pituitary gonadal axis in vivo and in vitro in male rats. Endocrinology 140: 5459-5462
34. Nandha KA, Benito-Orfila MA, Smith DM, Bloom SR 1993 Characterization of the rat uterine neuromedin U receptor. Endocrinology 133:482-486
35. Fray PJ, Sahakian BJ, Robbins TW, Koob GF, Iversen SD 1980 An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-amphetamine and apomorphine. Psychopharmacology 69:253-259
36. Abbott CR, Rossi M, Wren AM, Murphy KG, Kennedy AR, Stanley SA, Zollner AN, Morgan DG, Morgan I, Ghatei MA, Small CJ, Bloom SR 2001 Evidence of an orexigenic role for cocaine- and amphetamine regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology 142:3457-3463
37. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal I, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR 2001 Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547
38. Russell SH, Small CJ, Dakin CL, Abbott CR, Morgan DG, Ghatei MA, Bloom SR 2001 The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol 13:561-566
39. Bloom SR, Long RG 1982 Radioimmuonassays of Gut Regulatory Peptides. Philadelphia: Saunders
40. Park TH, Carr KD 1998 Neuroanatomical patterns of fos-like immunoreactivity induced by a palatable meal and meal-paired environment in saline and naloxone-treated rats. Brain Res 805:169-180
41. Wilding JP, Gilbey SG, Mannan M, Aslam N, Ghatei MA, Bloom SR 1992 Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats. J Endocrinol 132: 299-304
42. Hanada R, Nakazato M, Murakami N, Sakihara S, Yoshimatsu H, Toshinai K, Hanada T, Suda T, Kangawa K, Matsukura S, Sakata T 2001 A role for neuromedin U in stress response. Biochem Biophys Res Commun 289:225-228
43. Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W 1982 Corticotropin releasing factor produces behavioural activation in rats. Nature 297:331-333
44. Dunn AJ, Berridge CW, Lai YI, Yachabach TL 1987 CRF-induced excessive grooming behavior in rats and mice. Peptides 8:841-844
45. Morley JE, Levine AS 1982 Corticotrophin releasing factor, grooming and ingestive behavior. Life Sci 31:1459-1464
46. Chrousos GP 2000 The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 24(Suppl 2):S50-S55